Verikai

Verikai

AI-powered predictive risk scoring for underwriting

Overview

Verikai provides a predictive data and risk platform for the insurance industry. Its AI-powered Capture scores analyze behaviors of millions of individuals to help insurers improve underwriting accuracy and efficiency. The product works by processing large-scale data with machine learning models to generate risk insights, delivered through a subscription-based service that insurers integrate into their risk assessment workflows. Compared with competitors, Verikai specializes in insurance-focused predictive data and performance-based Capture scores, offering a steady subscription revenue model and a focus on actionable underwriting insights. The company’s goal is to help insurers achieve more accurate risk evaluation and drive profitable growth.

About Verikai

Simplify's Rating
Why Verikai is rated
D+
Rated D+ on Competitive Edge
Rated D+ on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Financial Services

Company Size

1-10

Company Stage

Acquired

Total Funding

$6M

Headquarters

San Francisco, California

Founded

2018

Get referred to Verikai

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AFG's ownership gives Verikai balance-sheet support and distribution through Great American Insurance Group.
  • Med/Rx and Capture360 deepen group-health underwriting workflows with same-day reporting.
  • Verikai's claims-history and behavioral scoring still saves underwriters time on submissions.

What critics are saying

  • AFG wound down Verikai as a standalone business on February 8, 2026.
  • LinkedIn shows Verikai at one employee, signaling severe downsizing and integration.
  • Insurers can switch to competitors like LexisNexis and Verisk, eroding Verikai's niche.

What makes Verikai unique

  • Verikai combines medical, pharmaceutical, behavioral, and SDoH data for underwriting scores.
  • CaptureHealth and Capture360 cover 330 million Americans across dozens of curated data sources.
  • AFG bought Verikai in December 2021 for about $120 million cash.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$6M

Below

Industry Average

Funded Over

2 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Company News

Business Wire
Feb 29th, 2024
Verikai Redefines Healthcare Decision-Making With The Unveiling Of Capturehealth And Capture360

SAN FRANCISCO--(BUSINESS WIRE)--Verikai, an industry innovator in health insurance, proudly announces the launch of CaptureHealth and Capture360, two groundbreaking solutions designed to revolutionize healthcare risk analysis. These offerings are part of the comprehensive Verikai platform. The CaptureHealth model provides a health-centric risk score by feeding comprehensive medical claim and health history data into Verikai's proprietary machine learning models. Capture360 adds hundreds of thousands of behavioral and social determinants of health (SDoH) factors to CaptureHealth in order to deliver the most accurate and comprehensive risk score in the market. Verikai's breakthrough scoring technology uniquely combines dozens of sources of curated medical and pharmaceutical data covering over 330 million Americans, with behavioral attributes and SDoH, offering unparalleled precision in health risk assessment. CaptureHealth and Capture360 collectively address longstanding industry challenges, offering concise and comprehensive views of claims histories while simplifying the task of assessing medical and pharmaceutical risks

Coverager
Sep 16th, 2022
Verikai Launches Med/Rx

Insurance technology startup Verikai is launching Med/Rx for carriers to run group reports through Verikai’s platform to establish a baseline of high-cost conditions and prescriptions that appear in each group. The Med/Rx report includes 10,000 of the most expensive medical diagnoses, including cancers, chronic illnesses, mental disorders, injuries, and drug abuse – to name a few. The Rx half of the report provides all known prescription data on a group, broken down by pricing category (generic, brand, and specialty drugs). As Med/Rx takes shape, Verikai will continue to update the product with additional medical conditions and deeper insights into price

Verikai
Apr 13th, 2022
Verikai, Inc. recognized as #3 on the list as an innovative leader in insurance technology

Verikai is featured as #3 on the list as an innovative leader in insurance technology.

Business Wire
Jan 18th, 2022
American Financial Group, Inc. Announces Purchase Of Verikai, Inc.

CINCINNATI--(BUSINESS WIRE)--American Financial Group (NYSE: AFG) announced today the acquisition of Verikai, Inc. (“Verikai"), a machine learning and artificial intelligence company that utilizes a predictive risk tool for assessing insurance risk, effective December 2021. Verikai will continue to be led by its President and CEO, Jeff Chen. AFG paid approximately $120 million in cash at closing. Carl H. Lindner III, AFG’s Co-CEO, stated: “We are thrilled to welcome the Verikai team to AFG. We

Business Wire
Jan 18th, 2022
American Financial Group Inc acquired Outcomes2Outreach on Jan 18th 22'.

American Financial Group (NYSE: AFG) announced today the acquisition of Verikai, Inc. (“Verikai"), a machine learning and artificial intelligence company that utilizes a predictive risk tool for assessing insurance risk, effective December 2021.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Verikai right now.

Find jobs on Simplify and start your career today

We update Verikai's jobs every few hours, so check again soon! Browse all jobs →